Drug Pipeline

HC-7366 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06234605 A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell… Renal Cell Carcinoma Recruiting
NCT07401875 A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK) Phase 1b Recruiting
NCT06285890 Phase I Study of HC-7366 for Acute Myeloid Leukemia Acute Myeloid Leukemia Recruiting
Sponsors Running HC-7366 Trials
M.D. Anderson Cancer Center (2) HiberCell, Inc. (1)
Disease Areas
Kidney Cancer (2) Leukemia (1) Acute Myeloid Leukemia (AML) (1)
Get alerts when HC-7366 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free